Faster Medical Device Licences Could Unlock Crores in Investment

Medical Device Licences could soon become easier and quicker to obtain in India, a move that may do more than reduce paperwork.

The proposed changes are expected to help manufacturers start production earlier, unlock investments worth crores, and improve the ease of doing business.

While the government has reduced only a few days from the approval process, industry experts say Medical Device Licences play a key role in deciding how fast factories begin operations and how quickly companies can bring products to the market.

The proposal, issued by the Central Drugs Standard Control Organisation (CDSCO), seeks to revise approval timelines under the Medical Devices Rules without changing existing quality, safety, or performance standards. If implemented, the new timelines could benefit both domestic manufacturers and global companies looking to expand production in India.

How the proposed timelines will change

The proposal does not dilute regulatory requirements. Manufacturers will still have to meet the same standards for product quality, safety, and performance before receiving approval.

Why faster approvals matter beyond paperwork

A shorter approval process can have a significant financial impact on medical device manufacturers. Companies often invest heavily in factory infrastructure, machinery, workforce hiring, and inventory before commercial production begins. Delays in obtaining Medical Device Licences can keep these investments idle while increasing operating costs.

With approvals arriving earlier, manufacturers can:

• Start commercial production sooner.
• Generate revenue faster.
• Reduce the cost of idle factories and equipment.
• Improve cash flow and investor confidence.
• Speed up the launch of new medical devices.

For startups and small manufacturers, these savings could be even more important, as quicker approvals help reduce the time between investment and market entry.

The proposal also supports India's broader goal of strengthening domestic medical device manufacturing and reducing dependence on imports for high-value products.

A step toward stronger MedTech manufacturing

India has been working to position itself as a global manufacturing hub for medical devices through policy reforms, production-linked incentives, and dedicated medical device parks. Faster licensing is another step that could make the country more attractive for investment.

Products such as cardiac stents, orthopedic implants, blood pressure monitors, diagnostic equipment, and other medical devices may benefit from quicker manufacturing approvals if companies can establish production facilities in less time.

However, industry stakeholders believe faster timelines should also be supported by efficient inspections and adequate regulatory capacity. Maintaining product quality while processing applications more quickly will remain critical for patient safety and industry confidence.

The revised timelines are currently part of a draft notification. Stakeholders have been invited to submit their comments before the proposal is finalized. Once implemented, the changes could help reduce regulatory delays while encouraging fresh investment in India's growing MedTech sector.